Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:1.1.1.28 (
lactic acid dehydrogenase
)
476
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The Escherichia coli membrane-bound
D-lactate dehydrogenase
and succinate dehydrogenase were assayed on the basis of the phenazine methosulfate- (PMS-) mediated reduction of the tetrazolium salt, MTT. An initial slower phase (lag) in the time-course of the reaction was observed and analyzed. The results were as follows. (1) The time lag in the assay of the
D-lactate dehydrogenase
was eliminated by preincubating the membranes with
PMS
plus D-lactate, with
PMS
plus succinate, or with
PMS
plus NADH (conditions which implicated
PMS
reduction). (2) When the
D-lactate dehydrogenase
was assayed by another method based on the measurement of the pyruvate formed, neither was a time lag observed nor was the enzyme activity affected by membrane preincubation with
PMS
plus D-lactate. (3) Although the superoxide radical was involved in MTT reduction, this radical seemed not to participate in the generation of the time lag. (4) Membranes whose
D-lactate dehydrogenase
activity had previously been destroyed by heating at 80 degrees C for 1 min, were able to prolong the time lag in MTT reduction when added to the assay medium for the
D-lactate dehydrogenase
from untreated membranes, whereas membranes previously heated at 100 degrees C instead of 80 degrees C did not have this effect. It was concluded that the E. coli membranes interfered in the dehydrogenase assay based on the
PMS
-mediated reduction of MTT. The time lag was interpreted as a period during which the interfering substance reacted with reduced
PMS
inhibiting the reduction of MTT.
...
PMID:Study of a time lag in the assay of Escherichia coli membrane-bound dehydrogenases based on tetrazolium salt reduction. 388 Nov 33